Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Chiasserini

Showing results (81-90 of 88) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 88 results.
Cell Reports|December 8, 2021
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosisMassimiliano Di Filippo, Andrea Mancini, Laura Bellingacci, et al.
International Journal of Cancer|August 15, 2019
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progressionMalgorzata A Komor, Meike de Wit, Jose van den Berg, et al.
Molecular & Cellular Proteomics : MCP|August 9, 2023
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative DementiasCharlotte E Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Nature Communications|October 17, 2020
Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studiesYue Xuan, Nicholas W Bateman, Sebastien Gallien, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2016
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia DiagnosticsNatalia Lelental, Sebastian Brandner, Olga Kofanova, et al.
Nature Medicine|February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disordersKatharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
Pageof 9

Showing results (81-90 of 88) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 88 results.
Cell Reports|December 8, 2021
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosisMassimiliano Di Filippo, Andrea Mancini, Laura Bellingacci, et al.
International Journal of Cancer|August 15, 2019
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progressionMalgorzata A Komor, Meike de Wit, Jose van den Berg, et al.
Molecular & Cellular Proteomics : MCP|August 9, 2023
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative DementiasCharlotte E Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Nature Communications|October 17, 2020
Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studiesYue Xuan, Nicholas W Bateman, Sebastien Gallien, et al.
Journal of Alzheimer'S Disease : JAD|March 12, 2016
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia DiagnosticsNatalia Lelental, Sebastian Brandner, Olga Kofanova, et al.
Nature Medicine|February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disordersKatharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 26, 2011
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkersNiklas Mattsson, Ulf Andreasson, Staffan Persson, et al.
Pageof 9